Sophia Genetics clinches $77M Series E and 850 hospital connections for data-driven medicine breakth

SOPHiA GENETICS is a data-driven medicine software company with headquarters in Lausanne, Switzerland and Boston, Massachusetts[2].[3][4][5] It provides genomic and radiomic analysis for hospitals, laboratories, and biopharma institutions.[6][7] The company was ranked among the 50 smartest companies by the MIT Technology Review in 2017.[8] The company went public on the Nasdaq in 2021, floating at $1.1B.[9]

The company initially designed the platform to help hospitals with processing and storing large genomic data-sets, but research showed that the more pressing problem was data accuracy.[13] That then became the platform's primary focus. The startup worked with hospitals to benchmark DNA samples analyzed via their sequencing systems, and then trained algorithms of their own to perform the diagnosing process automatically and recognize relevant patterns in the genome data.[13] The algorithms were built bottom-up from raw FASTQ data.[13]

Sophia Genetics bags $77M Series E, with 850 hospitals signed up to its data-driven medicine

Download: https://0nicuforwo.blogspot.com/?file=2vBIxg

2ff7e9595c